Physician profile
Debra E Towery
NPI 1184026130
$1,832.10
in general payments reported to CMS, 2019-2025
25 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,769 · 2022: $47.46 · 2023: $15.98.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $15.98.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $15.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $229.09 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $226.43 | 2021 | |
| Abbvie INC. | $172.10 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $166.04 | 2021 | |
| Amgen INC. | $115.00 | 2021 | |
| Bausch Health US, LLC | $110.22 | 2021 | |
| Glaxosmithkline, LLC. | $96.28 | 2021-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $81.81 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $68.31 | 2021 | |
| Abbott Laboratories | $62.85 | 2021 | |
| Novartis Pharmaceuticals Corporation | $58.95 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $57.47 | 2021 | |
| Merck Sharp & Dohme LLC | $56.38 | 2021-2023 | Bridion |
| Esperion Therapeutics, INC. | $50.96 | 2021 | |
| Janssen Pharmaceuticals, INC | $44.27 | 2021 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mylan Specialty L.P. | $36.99 | 2021 | |
| Amarin Pharma, INC. | $36.15 | 2021 | |
| Pfizer INC. | $33.88 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $31.80 | 2021 | |
| Sanofi-Aventis U.S. LLC | $19.84 | 2021 | |
| Boston Scientific Corporation | $17.02 | 2021 | |
| Dexcom, INC. | $16.97 | 2021 | |
| Lilly USA, LLC | $16.70 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $13.66 | 2021 | |
| Eisai INC. | $12.93 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Debra Towery listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.